Natco Pharma Q2 net surges 83% to ₹677 crore on robust growth in formulation exports
The Hindu
Natco Pharma's Q2 profits soar 83% to ₹676.5 crore, driven by robust exports and stable domestic business.
Generic drugmaker Natco Pharma consolidated net profit surged 83% to ₹676.5 crore for the quarter ended September, from ₹369 crore a year earlier, on the back of a robust growth in formulations exports.
Total revenue of the company, which is also into crop protection products, increased 35.3% to ₹1,434.9 crore (₹1,060.8 crore) despite a decline in the contribution of active pharmaceutical ingredients (APIs) and crop health sciences business (CHS) segments.
The company has shown continued strong growth during the second quarter driven by exports formulation business and stable domestic pharma business, Natco Pharma said.
₹1.50 interim dividend
The company has declared a second interim dividend of ₹1.50 per equity share, for FY 2024-25. The record date is November 25 and the payment of interim dividend will start from December 2, it said.
Formulations exports for the second quarter at ₹1,211.3 crore (₹792.3 crore). For the June quarter, it was Rs.₹1210.1 crore, segmental revenue details showed.
Formulations revenue from the domestic market was flat at ₹102.3 crore (₹102.5 crore). Other operating and non-operating income rose to ₹57.6 crore (₹32.4 crore). Share of API in total revenue was lower year on year at ₹49.6 crore (₹77.8 crore). For the June quarter, it stood at ₹39.2 crore. CHS revenue totalled ₹14.1 crore as against ₹55.8 crore a year earlier and ₹15.6 crore for the June quarter.
DGCA grants IndiGo exemption from night-duty limits for pilots amid widespread flight cancellations and operational disruptions.
RBI to launch a two-month campaign in January 2026 to address pending grievances with the Ombudsman for improved customer service.
RBI plans ₹1 lakh crore OMO in December to boost liquidity amid upcoming tax payments, ensuring stability in the banking system.
IndiGo faces ongoing flight delays and cancellations due to technology issues, weather, and new crew rostering rules.
Stock markets experience volatility as investors await RBI's monetary policy amid foreign fund outflows and mixed global trends.
ED attaches assets worth ₹1,120 crore in Anil Ambani's Reliance Group case, totaling ₹10,000 crore amid money laundering probe.
Rupee rises 20 paise to 89.69 against the dollar as investors await RBI's monetary policy decision amidst market pressures.
Just nine Fugitive Economic Offenders (FEOs) owed Indian banks over ₹58,000 crore in principal and interest. To date, banks have recovered just over ₹19,000 crore — roughly 33% of the total dues.
Commerce Minister Piyush Goyal urges Indian businesses to seize opportunities in Russia's market, addressing talent shortages and trade demands.
Premiumisation is driving the growth in beauty and personal care industry in India and this segment is growing faster than the products made for the masses, industry executives said at Cosmoprof India 2025, a beauty & personal care industry event currently underway in Mumbai.
Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.
The Rupee appreciated by 19 paise to close at 89.96 against the U.S. dollar amid weak dollar index support.
India aims to expand its tea exports to China, highlighting diverse varieties like Darjeeling and Masala at a recent buyer-seller meet.